Skip to main navigation Skip to search Skip to main content

The clinical and cost-effectiveness of immunophrophylaxis against respiratory syncytial virus with palivizumab in children. Report number 66, 2007

  • Dechao Wang
  • , Carole Cummins
  • , Susan Bayliss
  • , Josie Sandercock
  • , Amanda Burls

    Research output: Book/ReportCommissioned report

    Original languageEnglish
    PublisherNot Known
    ISBN (Print)9780704426467
    Publication statusPublished - 1 Jan 2007

    Bibliographical note

    Department of Public Health and epidemiology, University of Birmingham

    Cite this